United Kingdom · Question · Written question
UIN 92777
Rare Diseases: Drugs
Original
Introduced
21 September 2020
Last action
22 October 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 October 2020
Summary
To ask the Secretary of State for Health and Social Care, how many times a medicine for a rare disease, not eligible for the HST process, has received a conditional approval for reimbursement based on a managed access agreement or similar.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 September 2020
Written question
To ask the Secretary of State for Health and Social Care, how many times a medicine for a rare disease, not eligible for the HST process, has received a conditional approval for reimbursement based on a managed access agreement or similar.
Source: Commons
22 October 2020
Answer
The National Institute for Health and Care Excellence has made recommendations on two medicines for rare diseases through a managed access agreement that were not eligible for the evaluation through the highly specialised technologies process.These are:- ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-09-21/92777
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1236136
- uk · wq-1236136 · source updated 22 October 2020